Osel
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
320 Logue Ave 644, Mountain View, Califo...Phone Number
(650) 964-4679Website
www.oselinc.comRevenue
<$5 MillionIndustry
About Osel
Osel Org Chart
Is Osel your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Osel recently announced quarterly report
Osel, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Osel is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Osel launches new products
Check if Osel has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Osel has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Osel had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Osel
Recommended Actions
Find VP level buyers at Osel
Find more new buyers
Compare Similar Companies to Osel
Compare insights from companies similar to Osel, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Osel is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Osel is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Osel.
Osel Tech Stack
A closer look at the technologies used by Osel
Osel News & Media
City of Hope and Osel Announce Exclusive License for Intellectual Property on the Use of Live Biotherapeutic Product CBM588 for Oncology Therapeutic Applications
DUARTE, Calif. & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--City of Hope grants Osel exclusive worldwide license for IP on novel use of live biotherapeutic product to enhance efficacy of checkpoint inhibitors.Osel Announces Positive Results from Phase 1b Trial of Live Biotherapeutic Product CBM588 in Combination with Checkpoint Inhibitor (CPI) Therapy in Metastatic Renal Cell Carcinoma
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Osel announces positive results presented at ASCO for Phase 1b trial of live biotherapeutic product CBM588 combined with checkpoint inhibitor therapy.Osel Obtains Exclusive License from Danish Research Consortia for IP Related to Osel’s LACTIN-V in Women Undergoing In-Vitro Fertilization
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Osel, Inc. has obtained the exclusive worldwide license to inventions resulting from an investigator-initiated Phase 2 trial of LACTIN-V in IVF.Osel’s Live Biotherapeutic Product Demonstrates Efficacy in Phase 2b Study of Bacterial Vaginosis
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Results for Osel’s Ph.2b study of LACTIN-V LBP published in NEJM demonstrating significantly reduced recurrence of bacterial vaginosis vs. placebo.
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Osel
Osel Inc. is a clinical-stage biopharma company focused on pioneering live biotherapeutic products (LBPs) aimed at improving health by harnessing the microbiome. The company is particularly active in oncology, with ongoing clinical trials for its lead candidate, MO-03, which is being tested in combination with standard immuno-oncology regimens for... Read More